日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase II Trial of Hypofractionated Radiotherapy and Immunochemotherapy in Primary Refractory Diffuse Large B-Cell Lymphoma: Preliminary Results and Insights from Digital Spatial Profiling.

原发性难治性弥漫性大B细胞淋巴瘤的低分割放射治疗和免疫化疗的II期试验:数字空间分析的初步结果和见解

Yang Yong, Yu Jing, Hu Xiao-Mei, Chen Si-Lin, Zhao Rui-Zhi, Huang Cheng, Guo Jiang-Rui, Tang Tian-Lan, Chen Cheng, Lin Yu-Ping, Wang Ying, Liu Tian-Xiu, Zheng Hao, Liao Si-Qin, Chen Jin-Hua, Fu Hai-Ying, Liu Ting-Bo

Rethinking bone marrow biopsy: is PET/CT enough for staging low-grade follicular lymphomas?

重新思考骨髓活检:PET/CT 是否足以对低级别滤泡性淋巴瘤进行分期?

Chen, Yan-Yan; Wang, Ji-Jin; Zhong, Wen-Huan; Guo, Jiang-Rui; Qiu, Yan-Yan; Liu, Tian-Xiu; Zheng, Hao; Chen, Si-Lin; Liao, Si-Qin; Zhao, Rui-Zhi; Shi, Gui-Qing; Tang, Tian-Lan; Lin, Yu-Ping; Huang, Cheng; Chen, Jin-Hua; Liu, Ting-Bo; Zhang, Yu-Jing; Yang, Yong

The immunodominant and neutralization linear epitopes for SARS-CoV-2

SARS-CoV-2 的免疫显性和中和线性表位

Shuai Lu, Xi-Xiu Xie, Lei Zhao, Bin Wang, Jie Zhu, Ting-Rui Yang, Guang-Wen Yang, Mei Ji, Cui-Ping Lv, Jian Xue, Er-Hei Dai, Xi-Ming Fu, Dong-Qun Liu, Lun Zhang, Sheng-Jie Hou, Xiao-Lin Yu, Yu-Ling Wang, Hui-Xia Gao, Xue-Han Shi, Chang-Wen Ke, Bi-Xia Ke, Chun-Guo Jiang, Rui-Tian Liu